Back
Sarepta Therapeutics Vs. IonQ Industry Stock Comparison
Buy
57
SRPT
Sarepta Therapeutics
Last Price:
$99.75
Seasonality Move:
6.73%
Sell
16
IONQ
IonQ
Last Price:
$18.26
Seasonality Move:
-3.86%
Buy
57
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $103.03. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $103.03Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
IONQ Stock Price Chart
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.04 | Sell |
Relative Strength Index (14 RSI): | 40.42 | Sell |
Chaikin Money Flow: | -321546 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (104.54 - 113.06) | Sell |
Bollinger Bands (100): | (110.42 - 127.2) | Sell |
IONQ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.73 | Sell |
Relative Strength Index (14 RSI): | 23.28 | Sell |
Chaikin Money Flow: | -1236268 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.76 - 40.68) | Sell |
Bollinger Bands (100): | (20.07 - 41.65) | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 104.67 | Sell |
20-day SMA: | 107.25 | Sell |
50-day SMA: | 114.66 | Sell |
200-day SMA: | 126.84 | Sell |
8-day EMA: | 105.01 | Sell |
20-day EMA: | 107.54 | Sell |
50-day EMA: | 112.76 | Sell |
200-day EMA: | 121.2 | Sell |
IONQ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.57 | Sell |
20-day SMA: | 31.33 | Sell |
50-day SMA: | 37.17 | Sell |
200-day SMA: | 19.31 | Buy |
8-day EMA: | 23.85 | Sell |
20-day EMA: | 29.17 | Sell |
50-day EMA: | 32.72 | Sell |
200-day EMA: | 23.7 | Sell |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.42 per share, an increase next quarter of $0.15 per share, an increase this year of $6.18 per share, and an increase next year of $5.61 per share.
IonQ Earnings Growth & IONQ Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and an increase next year of $0.07 per share.
Sarepta Therapeutics Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
IonQ Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |